Epigenetic Cancer Therapy 2015
DOI: 10.1016/b978-0-12-800206-3.00021-5
|View full text |Cite
|
Sign up to set email alerts
|

Emerging Epigenetic Therapies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 175 publications
0
2
0
Order By: Relevance
“…Moreover, quercetin inhibits COX-2 and TLR4 activity to reduce inflammatory responses [6,39,148]. Interestingly, quercetin may have epigenetic mechanisms by inhibiting lysine acetyltransferase (KAT) activity [150,151] and increasing lysine deacetylase (KDAC) activity [152], suggesting that the flavonoid can bidirectionally regulate autophagy [153], neuroinflammation, and apoptosis [154]. Quercetin also inhibits acetylcholinesterase (AChE) [155], which can enhance alertness and cognitive function in AD patients.…”
Section: Quercetinmentioning
confidence: 99%
“…Moreover, quercetin inhibits COX-2 and TLR4 activity to reduce inflammatory responses [6,39,148]. Interestingly, quercetin may have epigenetic mechanisms by inhibiting lysine acetyltransferase (KAT) activity [150,151] and increasing lysine deacetylase (KDAC) activity [152], suggesting that the flavonoid can bidirectionally regulate autophagy [153], neuroinflammation, and apoptosis [154]. Quercetin also inhibits acetylcholinesterase (AChE) [155], which can enhance alertness and cognitive function in AD patients.…”
Section: Quercetinmentioning
confidence: 99%
“…By interacting with CREBB binding protein (CBP), PCAF can activate the transcription depending on PCAF intrinsic histone acetyltransferase (HAT) activity 3 . PCAF is also a coactivator of the p53 gene target; acetylating K320 standardizes p53 enzymatic activity, promoting p53‐dependent p21 transcription and cell cycle arrest during the DNA damage process 4 . Structurally, PCAF (KAT2B) is a multidomain protein, the domains are namely, bromodomain (Brd), N‐terminal domain and HAT domain which is associated with CBP and p300 while in transcription and mis regulation of PCAF connected with cancer, HIV and neuroinflammation 5,6 …”
Section: Introductionmentioning
confidence: 99%
“…3 PCAF is also a coactivator of the p53 gene target; acetylating K320 standardizes p53 enzymatic activity, promoting p53-dependent p21 transcription and cell cycle arrest during the DNA damage process. 4 Structurally, PCAF (KAT2B) is a multidomain protein, the domains are namely, bromodomain (Brd), N-terminal domain and HAT domain which is associated with CBP and p300 while in transcription and mis regulation of PCAF connected with cancer, HIV and neuroinflammation. 5,6 Bromodomains are protein interaction modules, which recognize acetylation motifs, now it is emerged as an important therapeutic targets for many diseases, including inflammation and oncology.…”
Section: Introductionmentioning
confidence: 99%